-Economic and Political Weekly The importance of hand-washing in personal and public hygiene has evolved over the centuries. While the market with its countless number of soaps and hand-wash products for personal hygiene with the accompanying advertising has created a false sense of security, it is community hygiene implemented through public health measures that is really effective in the battle against disease. Lekha D Bhat (lekhabhatd@gmail.com) teaches at the Department of Social...

-The Times of India NEW DELHI: In a move that comes as a huge relief to patients of chronic Hepatitis C, the apex committee of the Central Drugs Standard Control Organisation (CDSCO) has granted a waiver of local trials for crucial new direct-acting antiviral drugs treating the disease. The waiver for sofosbuvir and ledipasvir co-formulation and for daclatasvir is expected to bring the generic version of these drugs, which cost a fraction...

-Hindustan Times School textbooks in recent decades have frequently become battlegrounds for ideological contestation in India. Most textbook wars are to advance majoritarian perspectives on history and culture. However, a recent very different textbook skirmish broke out about the public and private sectors in healthcare. The story of this ideological clash is bemusing and instructive, illuminating competing perspectives on the nature of education, healthcare and markets in new India. This clash surfaced...

-The Times of India NEW DELHI: Over 200 cancer drugs, 186 Medicines to treat cardiovascular diseases and 148 stents and cardiac implants will now be available at central government hospitals at prices 50-60% lower than the open market. The health ministry has launched a programme called AMRIT (Affordable Medicines and Reliable Implants for Treatment), under which the government will run pharmacy retail stores to sell Medicines in hospitals like All India Institute...

-The Times of India NEW DELHI: In an attempt to ease norms for testing and introduction of new Medicines in the country, the government has taken steps to fast-track approvals for clinical trials as well as launch of drugs already approved in other countries. Pharmaceutical companies planning to launch new drugs already approved outside India after conducting pre-clinical or toxicological studies on animals will not be required to repeat such studies in...